Back to funds
View filing
BOONE CAPITAL MANAGEMENT LLC
hedge fundUpdated 27 days agoManaged by Boone Capital Management Llc • Latest filing Q2 2026
Portfolio value
$427.5M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
15.6%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $213.6M |
| Q2 2023 | $278.6M |
| Q3 2023 | $317M |
| Q4 2023 | $428.4M |
| Q1 2024 | $494.4M |
| Q2 2024 | $383.4M |
| Q3 2024 | $385.8M |
| Q4 2024 | $296.5M |
| Q1 2025 | $293.8M |
| Q2 2025 | $233.2M |
| Q3 2025 | $305M |
| Q4 2025 | $318.6M |
| Q1 2026 | $326.4M |
| Q2 2026 | $427.5M |
Top holdings
16 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | T TFX TELEFLEX INCORPORATED | $49.1M | 387.4K | 11.49% | — |
| 2 | M MIRM MIRUM PHARMACEUTICALS INC | $48.7M | 415.6K | 11.38% | — |
| 3 | C CI THE CIGNA GROUP | $43.9M | 159.3K | 10.27% | — |
| 4 | I IONS IONIS PHARMACEUTICALS INC | $41.2M | 520.0K | 9.64% | — |
| 5 | U UNH UNITEDHEALTH GROUP INC | $36.9M | 88.7K | 8.62% | — |
| 6 | B BMRN BIOMARIN PHARMACEUTICAL INC | $33.4M | 583.2K | 7.81% | — |
| 7 | G GRDN GUARDIAN PHARMACY SVCS INC | $29.8M | 711.9K | 6.97% | — |
| 8 | V VSTS VESTIS CORPORATION | $27.6M | 1.90M | 6.45% | — |
| 9 | B BBIO BRIDGEBIO PHARMA INC | $25.3M | 339.7K | 5.92% | — |
| 10 | P PNTG PENNANT GROUP INC | $19.1M | 515.8K | 4.46% | — |
| 11 | M MNST MONTE ROSA THERAPEUTICS INC | $14.9M | 615.3K | 3.48% | — |
| 12 | K KOD KODIAK SCIENCES INC | $14.7M | 378.0K | 3.44% | — |
| 13 | T TNGX TANGO THERAPEUTICS INC | $14.2M | 455.6K | 3.33% | — |
| 14 | K KYMR KYMERA THERAPEUTICS INC | $13M | 113.2K | 3.04% | — |
| 15 | C CGEM CULLINAN THERAPEUTICS INC | $12.8M | 704.4K | 3.00% | — |
| 16 | A ANL ADLAI NORTYE LTD | $3M | 258.4K | 0.69% | — |